Results 141 to 150 of about 27,286 (175)
Some of the next articles are maybe not open access.

Therapeutic Applications of AS1411 Aptamer, an Update Review

International Journal of Biological Macromolecules, 2020
Nucleolin or C23, is one of the most abundant non-ribosomal phosphoproteins of nucleolus. However, in several cancers, nucleolin is highly expressed both intracellularly and on the cell surface. So, it is considered as a potential target for the diagnosis and cancer therapy.
Mohammad Ramezani   +2 more
exaly   +3 more sources

Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411 [PDF]

open access: yesCancer Investigation, 2018
AS1411 is an antiproliferative DNA aptamer, which binds the ubiquitous protein, nucleolin. In this study, we show that constitutive overexpression of nucleolin confers increased sensitivity to the growth inhibitory effects of AS1411. HeLa cells overexpressing nucleolin have an increased growth rate and invasiveness relative to control cells.
Shelia D Thomas   +2 more
exaly   +3 more sources

The effect of AS1411 aptamer on anti-tumor effects of dendrimers containing SN38

Journal of Drug Delivery Science and Technology, 2022
Objective: Although 7-Ethyl-10-hydroxy-camptothecin (SN38) is the most physiologically active of the camptothecin, its application has been limited due to its poor solubility in pharmaceutical solvents. Irinotecan is a prodrug of SN38 and the only commercially available formulation of this group.
Kiana Sherkat Sadi   +4 more
openaire   +1 more source

Corneal neovascularization is inhibited with nucleolin-binding aptamer, AS1411

Experimental Eye Research, 2020
Corneal neovascularization (CNV) is a common sight-threatening pathology that can be induced by a variety of inflammatory and angiogenic stimuli. Current CNV treatments include anti-inflammatory drugs and antibody-based inhibitors of vascular endothelial growth factor (VEGF).
Oscar, Vivanco-Rojas   +8 more
openaire   +2 more sources

Aptamer AS1411 utilized for super-resolution imaging of nucleolin

Talanta, 2020
Nucleolin (NCL) is a multifunctional protein that mainly localizes in the nucleolus and also distributes in the nucleoplasm, cytoplasm and cell membrane. Most studies focus on its biofunctions in cell activities and diseases, however, its detailed distribution and organization pattern in situ remains obscure.
Yingying, Jing   +5 more
openaire   +2 more sources

Aptamer Imaging With Cu-64 Labeled AS1411: Preliminary Assessment in Lung Cancer

Nuclear Medicine and Biology, 2014
AS1411 is a 26-base guanine-rich oligonucleotide aptamer shown binding to surface nucleolin, a protein over-expressed in multiple cancer cells, thus AS1411 labeled with a PET isotope can be explored as a potential diagnostic imaging agent. Our objective was to perform preliminary biological characterization of (64)Cu-labeled AS1411 in vitro and in vivo.
Chin K Ng, John O Trent, Huaiyu Zheng
exaly   +3 more sources

AS1411 Aptamer-Targeted Gold Nanoclusters Effect on the Enhancement of Radiation Therapy Efficacy in Breast Tumor-Bearing Mice

open access: yesNanomedicine, 2018
AIM: Herein, the AS1411 aptamer-targeted ultrasmall gold nanoclusters (GNCs) were assessed at different aspects as a radiosensitizer. MATERIALS & METHODS: AS1411 aptamer-conjugated gold nanoclusters (Apt-GNCs) efficacy was evaluated at cancer cells ...
Amirhosein Kefayat   +2 more
exaly   +2 more sources

The G-Quadruplex-Forming Aptamer AS1411 Potently Inhibits HIV-1 Attachment to the Host Cell [PDF]

open access: yesInternational Journal of Antimicrobial Agents, 2016
AS1411 is a G-rich aptamer that forms a stable G-quadruplex structure and displays antineoplastic properties both in vitro and in vivo. This oligonucleotide has undergone phase 2 clinical trials. The major molecular target of AS1411 is nucleolin (NCL), a
Sara Lago   +2 more
exaly   +2 more sources

AS1411 Aptamer Based Nanomaterials: A Novel Approach for Breast Cancer Therapy

International Journal of Biological Macromolecules
Breast cancer remains a leading cause of cancer-related mortality in women, accounting for 23.8 % of all female cancer cases. Existing therapies often lack tumor specificity, leading to severe off-target toxicity, dose-limiting side effects, and poor patient compliance. These limitations underscore the urgent need for innovative strategies that enhance
Shadma Wahab   +2 more
exaly   +3 more sources

AS1411 aptamer for targetable photosensitizer delivery

2009 International Conference on Biomedical and Pharmaceutical Engineering, 2009
A specialized G-quadruplex DNA aptamer with nucleolin targeting ability, AS1411, has been studied for cancer therapy. In this study, we report a novel delivery strategy for chemo-photodynamic combined treatment using AS1411 aptamer conjugated with tetra-(N-methyl-4-pyridyl)-porphine by intercalation and outside binding.
M. J. Shieh, Y. A. Shieh, P. S. Lai
openaire   +1 more source

Home - About - Disclaimer - Privacy